Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial

British Journal of Surgery

Volumn 97, Issue 6, 2010, Pages 826-834

  Lindholt, J S ^a   Sorensen J ^b   Sogaard R ^b   Henneberg, E W ^a  

^a VIBORG HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DENMARK; ECHOGRAPHY; ECONOMICS; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; PATIENT ATTITUDE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

AGED; AORTIC ANEURYSM, ABDOMINAL; COST-BENEFIT ANALYSIS; DENMARK; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77952750448     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7001     Document Type: Article

References (31)

1. Ash ton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RA. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007; 94: 696-701.
2. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA. et al.; Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360: 1531-1539.
3. Kim LG, P Scott RA, Ashton HA, Thompson SG; Multicentre Aneurysm Screening Study Group. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007; 146: 699-706.
4. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005; 330: 750.
5. Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ et al. Population based randomised controlled trial on impact of screening on mortality from abdominal, aortic aneurysm. BMJ 2004; 329: 1259.
6. Kim LG, Thompson SG. Uncertainty and validation of health economic decision models. Health Econ 2010; 19: 43-55.
7. Campbell H, Briggs A, Buxton M, Kim L, Thompson S. The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. J Health Serv Res Policy 2007; 12: 11-17. (Pubitemid 46174200)
8. Thompson SG, Ashton HA, Gao L, Scott RA; Multicentre Aneurysm Screening Study Group. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study. BMJ 2009; 338: b2307.
9. Ehlers L, Overvad K, Sørense.11 J, Christensen S, Bech M, KJølby M. Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm. BMJ 2009; 338: b2243.
10. Multicentre Aneurysm Screening Study Group. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ 2002; 325: 1135.
11. Kim LG, Thompson SG, Briggs AH, Buxton MJ, Campbell HE. How cost-effective is screening for abdominal aortic aneurysms? J Med Screen 2007; 14: 46-52.
12. Henriksson M, Lundgren F. Decision-analytical model with lifetime estimation of costs and health outcomes for one-time screening for abdominal aortic aneurysm in 65-year-old men. Br J Surg 2005; 92: 976-983.
13. Montreuil B, Brophy J. Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates. Can J Surg 2008; 51: 23-34.
14. Wanhainen A, Lundkvist J, Bergqvist D, BjörckM. Cost-effectiveness of different screening strategies for abdominal aortic aneurysm. J Vasc Surg 2005; 41: 741-751.
15. Silverstein MD, Pitts SR, Chaikof EL, Ballard DJ. Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA. Proc (Bayl Univ Med Cent) 2005;18:345-367.
16. Jensen LP, Lindholt JS, Schroeder TV. The Danish Health Economic Modelling Study on AAA Screening is Flawed. http://www.bmj.com/cgi/eletters/338/ jun24-2/b2243 [accessed 1 February 2010].
17. Chichester Aneurysm Screening Group; Viborg Aneurysm Screening Study; Western Australian Abdominal Aortic Aneurysm Program; Multicentre Aneurysm Screening Study. A comparative study of the prevalence of abdominal aortic aneurysms in the United Kingdom, Denmark, and Australia. J Med Screen 2001; 8: 46-50.
18. Lindholt JS, Juul S, Fasting H, Henneberg EW. Cost-effectiveness analysis of screening for abdominal aortic aneurysms based on five year results from a randomised hospital based mass screening trial. Eur J Vasc Endovasc Surg 2006;32:9-15. (Pubitemid 43842757)
19. Lindholt JS, Juul S, Henneberg EW. High-risk and low-risk screening for abdominal aortic aneurysm both reduce aneurystn-related mortality. A stratified analysis from a single-centre randomised screening trial. Eur J Vasc Endovasc Surg 2007; 34: 53-58. (Pubitemid 46852377)
20. Lindholt JS, Juul S, Fasting H, Henneberg EW. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from, a randomised population screening tri al. Eur J Vasc Endovasc Surg 2 002; 2 3: 55-60.
21. Jensen LP. Annual Report. 2008. The Danish Vascular Registry: Copenhagen, 2009.
22. Lindholt JS, SorensenJ. Hospital costs for operation for abdominal aortic aneurysm. Ugeskr Laeger 2009; Epub 2 Nov 2009.
23. Sørensen J, Davidsen M, Gudex C, Pedersen KM, Brannum-Hansen H. Danish EQ-5D population norms. Scand J Public Health 2009; 37: 467-474.
24. Lederle FA, Johnson GR, Wilson SE, Acher CW, Ballard DJ, Littooy FN et al.; Aneurysm Detection and Management Veterans Affairs Cooperative Study. Quality of life, impotence, and activity level in a randomized trial of immediate repair versus surveillance of small abdominal aortic aneurysm. J Vasc Surg 2003; 38: 745-752.
25. Prinssen M, Buskens E, Blankensteijn JD; DREAM trial participants. Quality of life after endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg 2004; 27: 121-127.
26. UK Small Aneurysm Trial Participants. Health service costs and quality of life for early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998; 352: 1656-1660. (Pubitemid 28526123)
27. Drummond M. Methods for the Economic Evaluation of Health Care Programmes. Oxford Medical Pubications: Oxford, 2005.
28. Hoch JS. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Earn 2002; 11: 415-430.
29. Stinnett AA. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med DecisMaking 1998; 18: S68-S80.
30. Rawlins MD. National Institute for Clinical Excellence and its value judgments. BMJ 2004; 329: 224-227.
31. Schouten O, van Laanen JHH, Boersma E, Vidakovic R, Feringa HH, Dunkelgrün M et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006; 32: 21-26. (Pubitemid 43842752)